Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Werewolf Therapeutics, Inc. shareholders
As of Sep 30, 2026, 44 institutions reported holding Werewolf Therapeutics, Inc., 26.4% of its shares. Largest: Balyasny Asset Management L.P., ADAR1 Capital Management, LLC and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Werewolf Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Balyasny Asset Management L.P. | 3.04M | 6.3% | +1.25M | Nov 16, 2026 |
| ADAR1 Capital Management, LLC | 2.02M | 4.2% | new | Nov 16, 2026 |
| Vanguard | 1.52M | 3.1% | +139K | Nov 13, 2026 |
| Lynx1 Capital Management LP | 658K | 1.4% | no change | Nov 16, 2026 |
| Sphera Funds Management LTD. | 627K | 1.3% | no change | Nov 16, 2026 |
| DC Funds, LP | 589K | 1.2% | no change | Nov 13, 2026 |
| Jane Street | 565K | 1.2% | +313K | Nov 12, 2026 |
| Citadel | 554K | 1.1% | new | Nov 16, 2026 |
| Renaissance Technologies | 551K | 1.1% | −124K | Nov 12, 2026 |
| Hrt Financial LP | 415K | 0.85% | new | Nov 13, 2026 |